Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

FTXH vs. RYHIX: which is better?

Bottom line

FTXH vs RYHIX: the short answer

FTXH (First Trust Nasdaq Pharmaceuticals ETF) and RYHIX (Health Care Fund) share a meaningful slice of their top holdings — about 52% by weight.

But RYHIX is far broader, holding 135 positions to 51 for FTXH, so beyond the top names it adds exposure FTXH doesn't have.

FTXH is cheaper at 0.6% vs 1.38% — a difference of $78 a year per $10,000 invested.

Over five years, FTXH returned +6.5% a year vs +5.1% for RYHIX.

Updated Nov 19, 2026

FTXH vs RYHIX side by side

FTXHRYHIX
TypeETFMutual fund
Fund familyFirst TrustGuggenheim
CategoryHealth Care SectorHealth Care Sector
Expense ratio0.6%1.38%
Annual cost per $10k$60$138
10-yr cost on $10k (prospectus)—$1,709
Max front loadNone—
12b-1 fee0%0%
1-yr return+24.0%+14.4%
5-yr return (annualized)+6.5%+5.1%
10-yr return (annualized)—+7.9%
Best quarter+18.3%+18.7%
Worst quarter−17.4%−14.4%
Net assets (fund)$36.2M$19.4M
Number of holdings51135
Portfolio turnover35%244%
Returns as ofDec 31, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearFTXHRYHIXDifference
2025+24.0%+14.4%+9.6%
2024+3.0%+0.6%+2.4%
2023−1.4%+5.8%−7.2%
2022+2.5%−11.6%+14.1%
2021+6.1%+19.2%−13.1%
2020+10.9%+18.9%−8.1%
2019+22.4%+22.8%−0.4%
2018−8.4%+1.6%−9.9%
2017+18.8%+23.5%−4.7%

Source: Fund prospectus bar charts

Holdings overlap

11 of FTXH's top 25 holdings also appear in RYHIX's top 25.

Shared top holdings
HoldingFTXHRYHIX
Eli Lilly & Company7.77%3.63%
Abbvie Inc7.39%2.52%
Merck & Company Inc7.07%2.04%
Johnson & Johnson6.96%2.88%
Bristol-myers Squibb Company6.29%1.22%
Cardinal Health Inc3.53%0.86%
Vertex Pharmaceuticals Inc3.41%1.34%
Amgen Inc3.18%1.56%
Pfizer Inc2.97%1.25%
Gilead Sciences Inc2.89%1.39%
Regeneron Pharmaceuticals Inc2.72%0.90%

Source: SEC Form N-PORT

FTXH top 10

  1. Eli Lilly & Company — 7.77%
  2. Abbvie Inc — 7.39%
  3. Merck & Company Inc — 7.07%
  4. Johnson & Johnson — 6.96%
  5. Bristol-myers Squibb Company — 6.29%
  6. Biogen Inc — 3.84%
  7. Viatris Inc — 3.62%
  8. Cardinal Health Inc — 3.53%
  9. Vertex Pharmaceuticals Inc — 3.41%
  10. Amgen Inc — 3.18%

RYHIX top 10

  1. Eli Lilly & Company — 3.63%
  2. Johnson & Johnson — 2.88%
  3. Abbvie Inc — 2.52%
  4. Unitedhealth Group Inc — 2.22%
  5. Merck & Company Inc — 2.04%
  6. Thermo Fisher Scientific Inc — 1.61%
  7. Amgen Inc — 1.56%
  8. Abbott Laboratories — 1.42%
  9. Gilead Sciences Inc — 1.39%
  10. Vertex Pharmaceuticals Inc — 1.34%

FAQ

What is the difference between FTXH and RYHIX?
FTXH (First Trust Nasdaq Pharmaceuticals ETF) and RYHIX (Health Care Fund) share a meaningful slice of their top holdings — about 52% by weight. But RYHIX is far broader, holding 135 positions to 51 for FTXH, so beyond the top names it adds exposure FTXH doesn't have.
Which is cheaper, FTXH or RYHIX?
FTXH has the lower expense ratio (0.6%).
Should I own both FTXH and RYHIX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.